Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
8%
Ph not_applicable
3
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed4
Not yet recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

not_yet_recruiting18%
completed433%
recruiting18%
unknown542%
withdrawn18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
12